Cargando…
Data mining patented antibody sequences
The patent literature should reflect the past 30 years of engineering efforts directed toward developing monoclonal antibody therapeutics. Such information is potentially valuable for rational antibody design. Patents, however, are designed not to convey scientific knowledge, but to provide legal pr...
Autores principales: | Krawczyk, Konrad, Buchanan, Andrew, Marcatili, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971238/ https://www.ncbi.nlm.nih.gov/pubmed/33722161 http://dx.doi.org/10.1080/19420862.2021.1892366 |
Ejemplares similares
-
Maximum-Entropy Models of Sequenced Immune Repertoires Predict Antigen-Antibody Affinity
por: Asti, Lorenzo, et al.
Publicado: (2016) -
Looking for therapeutic antibodies in next-generation sequencing repositories
por: Krawczyk, Konrad, et al.
Publicado: (2019) -
Mining chemical information from open patents
por: Jessop, David M, et al.
Publicado: (2011) -
Mining chemical patents with an ensemble of open systems
por: Leaman, Robert, et al.
Publicado: (2016) -
Tabhu: tools for antibody humanization
por: Olimpieri, Pier Paolo, et al.
Publicado: (2015)